Morning Movers - Sirius XM Radio (NASDAQ:SIRI) and BioCryst Pharmaceuticals (NASDAQ:BCRX),

New York, NY -- (SBWIRE) -- 04/01/2013 -- issues special report on the Morning movers – Sirius XM Radio (NASDAQ:SIRI),BioCryst Pharmaceuticals (NASDAQ:BCRX)

Sirius XM Radio (NASDAQ:SIRI) ratings have been reiterated by TheStreet Ratings with a buy having a ratings score of B.
The firm’s (SIRI) positive energy can be seen in different areas, including its revenue growth, robust stock price valuation, outstanding return on equity, growing profit margins and positive cash flow from operations.

How Sirius XM came under investors’ attention on Monday? Find out here

SIRI&aposs (SIRI) revenue growth has somewhat topped the industry average of 8.5%. Since the similar quarter in 2011, revenues climbed by 13.9%. This growth in revenue seems to have dropped down to the firm’s bottom line, enhancing the earnings per share.
Shares of Sirius XM Radio (NASDAQ:SIRI) were flirting with minor gains and losses and on last check were seen just below the trend line with negative change of -0.16% at 10:41 AM EDT.

An over-involved government-funded flu treatment candidate could move on ahead. That’s the expectation of Research Triangle Park pharma BioCryst Pharmaceuticals (NASDAQ:BCRX), after the receiving of two significant letters.
BioCryst has got a comment letter from the US Food and Drug Administration sketching a path by which a New Drug Application (NDA) could be submitted for the intravenous flu treatment.

How BioCryst is managing this situation on its own? Find out here

BioCryst (BCRX) has also got written notification, though, from its funder for the drug, the US Department of Health and Human Services, in the sort of a stop-work order, indicating the firm to halt work on peramivir.

About is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!

This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.

Read Our Full Disclaimer at:

For more information on this press release visit:

Media Relations Contact

Bobby Delp
Email: Click to Email Bobby Delp

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here